Source: FierceBiotech

Proteros: AstraZeneca puts further $75M up for grabs in expanded Proteros cancer drug deal

AstraZeneca puts further $75M up for grabs in expanded Proteros cancer drug deal gmasson Thu, 05/12/2022 - 14:52

Read full article »

Proteros's Competitors | Proteros's News | Proteros's Financials

Followers on Owler

172

Est. Annual Revenue

$5.0-25M

Est. Employees

100-250

Co-Founder & CEO

Torsten Neuefeind

CEO Approval Rating

85/100

Proteros is a Germany-based CRO that provides services such as drug discovery and biophysical testing for sectors including biotechnology and pharmaceuticals.